Loading clinical trials...
Loading clinical trials...
The purpose of this clinical research study is to learn whether subjects treated with aripiprazole are able to abstain from alcohol use for a greater number of days than subjects treated with placebo....
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborators
NCT06676059 · Alcoholism, Substance-Related Disorders
NCT06939088 · Alcohol Use Disorder, Alcohol Abuse/Dependence, and more
NCT06493773 · Liver Diseases, Alcoholic, Alcohol Use Disorder, and more
NCT04773691 · Alcoholism, rTMS Stimulation
NCT06916754 · Alcohol-Related Disorders, Alcoholism, and more
Local Institution
Farmington, Connecticut
Local Institution
New Haven, Connecticut
Local Institution
Indianapolis, Indiana
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions